Journal for ImmunoTherapy of Cancer (Nov 2021)
418 Phase 1b/2 KEYNOTE-365 cohort I: platinum-containing chemotherapy alone or in combination with pembrolizumab for treatment-emergent neuroendocrine prostate carcinoma
Abstract
No abstracts available.